A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses.

Abstract

This paper contributes to a small but growing body of evidence regarding the efficacy of value-based insurance design. In a retrospective, observational study of employees of a large global pharmaceutical firm, we evaluated how reduced patient cost sharing for prescription drugs for asthma, hypertension, and diabetes affected the use of these drugs and… (More)
DOI: 10.1377/hlthaff.2010.0510

Topics

Cite this paper

@article{Gibson2011AVI, title={A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses.}, author={Teresa Bernard Gibson and Sara Wang and Emily K Kelly and Candace Brown and Christine L. Turner and Feride H Frech-Tamas and Joseph Doyle and Edward Mauceri}, journal={Health affairs}, year={2011}, volume={30 1}, pages={109-17} }